Brief: Avid Bioservices sees FY revenue of USD 145-165 million
21/06/2023 22:32
Jun 21 (Reuters) - Avid Bioservices Q4 revenue USD 39.8 million vs. estimate USD 38.9 million. * Q4 gross margin 21% * Q4 net income USD -309 thousand * Q4 orders USD 55 million * Outlook FY revenue USD 145-165 million
Recent news on Avid Bioservices
See all newsBrief: Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction
Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce
Press Digest: Wall Street Journal - Nov. 7
Brief: Avid Bioservices to be acquired for $1.1 bln by GHO Capital Partners, Ampersand Capital Partners